Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Lecanemab for Alzheimer's Disease
Recruiting2 awardsPhase 3
Saint Louis, Missouri
This trial aims to treat individuals with a specific genetic mutation that causes Alzheimer's disease. They will be treated with a drug called lecanemab to see if removing amyloid plaques from the brain
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.